Claritine 10 mg

Loratadine 10 mg.

Pregnancy and Breastfeeding Warnings
Loratadine Pregnancy Warnings
Animal models have failed to reveal evidence of teratogenicity or embryotoxicity. There are no controlled data in human pregnancy. AU TGA pregnancy category B1: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have not shown evidence of an increased occurrence of fetal damage.
This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. AU TGA pregnancy category: B1 US FDA pregnancy category: Not formally assigned to a pregnancy category.

Loratadine Breastfeeding Warnings
Use is not recommended. Excreted into human milk: Yes

References for pregnancy information
  1. "Product Information. Claritin (loratadine)." Schering Laboratories, Kenilworth, NJ.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
References for breastfeeding information
  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Claritin (loratadine)." Schering Laboratories, Kenilworth, NJ.
  4. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Claritine 10 mg only for the indication prescribed.

Verified References
  • FDA Jan 06, 2018
  • CDC Jan 06, 2018
  • Mayo Clinic Jan 06, 2018
  • Drugs.com accessed Jan 06, 2018
  • Medscape accessed Jan 06, 2018
  • Epocrates accessed Jan 06, 2018
  • Webmd accessed Jan 06, 2018